Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepafenac for Pain in Intravitreal Injections
NCT02821390Completed
- Sponsor
- University General Hospital of Patras
- Start
- Jun 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nepafenac (2 arms), sponsored by University General Hospital of Patras. Primary endpoint: Visual Analogue Scale. Started Jun 2016; status: completed.
02
Drugs
nepafenac
Beyond the preview
Go deeper on NCT02821390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02821390.